logo

Xilio Therapeutics Inc (XLO) Stock: A Comprehensive 52-Week Review

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Xilio Therapeutics Inc’s current trading price is -55.96% away from its 52-week high, while its distance from the 52-week low is 46.53%. The stock’s price range over this period has fluctuated between $0.58 and $1.93. The company, operating within the financial sector, had a trading volume of approximately 0.69 million for the day, which was noticeably lower than the average daily share volume of 4.22 million over the last 3 months.

In terms of market performance, Xilio Therapeutics Inc had a fairly even. The highest value for the stock in the past year was $1.93 on 03/28/24, and the lowest value was recorded at $0.58 on 03/27/24.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Xilio Therapeutics Inc (XLO) has experienced a quarterly decline of -20.20% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 44.01M and boasts a workforce of 73 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.9822, with a change in price of +0.0407. Similarly, Xilio Therapeutics Inc recorded 2,611,739 in trading volume during the last 100 days, posting a change of +5.15%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for XLO stands at 0.40. Similarly, the long-term debt-to-equity ratio is also 0.35.

XLO Stock Stochastic Average

Today’s raw stochastic average for Xilio Therapeutics Inc over the last 50 days is 18.76%.This indicates a increase from the raw stochastic average of the past 20 days, which was 17.81%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 12.30% and 12.89%, respectively.

XLO Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. This year’s metric has recorded a Price decrease of -11.01%. However, over the past six months, we’ve seen a weaker performance of 9.62%. The price of XLO leaped by -42.57% over the last 30 days. And in the last five days, it has fallen by -6.45%.

Most Popular